Patient Power®
Get Email Alerts!
Health Topics
Lymphoma Health Center
Health Center Home Audio Programs Videos Conference Coverage
  • ASH 2011
    • Search by Keyword:
    Search by Health Topic:
    View all Health Topics >

    Lymphoma Videos

    New Follicular Lymphoma Therapies Bring Lower Toxicity and Side Effects
    The outlook for patients with follicular lymphoma is becoming increasingly bright.
    By: Patient Power
    New Hope for Patients with Mantle Cell Lymphoma
    New medicines are on the horizon for patients with Mantle Cell Lymphoma. Dr. Bertrand Coiffier discusses the latest progress and new treatments.
    By: Patient Power
    Small Molecules Bring Hope for Follicular Lymphoma Patients
    Dr Gilles Salles is optimistic about the latest developments in combining monocloncal antibodies with small molecule, targeted therapies (pills) in the treatment of Follicular Lymphoma.
    By: Patient Power
    New Antibody-Drug Conjugates for Lymphomas
    Dr. Oliver Press details what progress researchers are seeing using antibody-drug conjugates to treat lymphomas and the role B-cell lymphoma 2 (Bcl-2) inhibitors play.
    By: Patient Power
    Radioimmunotherapy-Based Transplants for Non-Hodgkin's Lymphoma
    Dr. Ajay Gopal explains the results from a recent, large study using radioimmunotherapy prior to transplant for Non-Hodkin's Lymphoma patients.
    By: Patient Power
    A Personal Perspective on CLL and Myelofibrosis Progress
    Andrew Schorr shares his optimism while attending the 2012 American Society of Hematology meeting in Atlanta, Georgia.
    By: Patient Power
    A Flow of New Options for Relapsed and Refractory Hodgkin Lymphoma
    Dr. Joseph Connors, a leader in lymphoma treatment from BC Cancer Agency in Vancouver, Canada, discusses treatment possibilities that could bring new hope to patients living with relapsed or refractory Hodgkin lymphoma.
    By: Patient Power
    Asking the Right Questions Could Save a Life
    Rory's death from a bacterial infection has important lessons for all of us. What questions could have saved his life? Hear Christopher's tips...
    By: Patient Power
    The RELEVANCE Trial: Investigating Combination Therapy for Follicular Lymphoma
    The RELEVANCE trial at Seattle Cancer Care Alliance is studying a chemotherapy-free combination therapy for follicular lymphoma. Dr. Edward Libby, the trial’s lead investigator, joins us to explain the details of the study and its goal to improve response rates and progression-free survival.
    By: Patient Power
    Kinase Inhibitors Offer New Hope for Mantle Cell Lymphoma
    Dr. Peter Martin explains clinical trials for this promising new treatment approach.
    By: Patient Power
    Results of the RESORT Trial for Follicular Lymphoma: Questions for Patients and Their Physicians
    Dr. Brad Kahl, co-author of the trial, gives an in-depth explanation of the many factors that patients should consider.
    By: Patient Power
    Fighting Cancer in Your 20s: Lessons Learned
    This is a podcast about Fighting Cancer in Your 20s: Lessons Learned, with Rose Egge.
    By: Patient Power
    By: Patient Power
    By: Patient Power
    By: Patient Power
    By: Patient Power
    By: Patient Power
    By: Patient Power
    Breakthroughs in Lymphoma
    Dr. Younes discusses two promising medicines for Hodgkin's disease and anaplastic large cell lymphoma
    By: Patient Power
    What Personalized “Precision” Medicine Means for Patients Today
    Dr. Tibes is researching the leading-edge of medical science in an effort to find unique properties of certain cancer subsets so targeted medicine can be developed against them.
    By: Patient Power
    Stem Cell Transplants Available to Expanding Group of Patients
    Dr. Jose Leis talks about stem cell transplants for older patients with blood cancers.
    By: Patient Power
    Fighting Drug Resistance: The CML Example
    Dr. Richard Larson talks about patients concerns over drug resistance and the role of old drugs.
    By: Patient Power
    On the Horizon: Chemo Drugs No Longer Needed?
    Dr. Ronald Levy talks about the possibility of no longer needing chemo and the role of antibodies.
    By: Patient Power
    The Promise of Vaccine Therapy for Blood Related Cancers
    Dr. Carl June discusses promising research surrounding vaccine therapy for patients with blood related cancers.
    By: Patient Power
    The Latest on Radioimmunotherapy for Lymphoma
    Dr. Oliver Press talks about emerging science using targeted therapy and the patients own immune system to fight disease like lymphoma, leukemia and multiple myeloma.
    By: Patient Power
    Lessons From a Five-Time Lymphoma Survivor
    Donald offers up his real-life experiences for those newly diagnosed with cancer. Hear his story...
    By: Patient Power
    Bendamustine + Rituxan vs. CHOP + R For Indolent Lymphomas
    Dr. Mathias Rummel talks about a new study form Germany that shows a 40-year-old drug, Bendamustine (Treanda), can be combined with Rituxan for more effective treatment and lower side effects than the standard approach, CHOP plus Rituxan.
    By: Patient Power
    An Experts Perspective on the Latest in NHL
    Dr. Ephraim Hochberg talks about clinical trials for lymphomas, maintenance therapy and relapse.
    By: Patient Power
    What's Old is New at ASCO
    Andrew, on location in Chicago, discusses how long it can take before a study is presented at ASCO and the role of clinical trials in giving patients access to the medicines of tomorrow, today.
    By: Patient Power
    Powerful Patient Update: Holly Trandel
    Holly Trandel is a newlywed who has taken extraordinary measures to preserve her fertility because she has had cancer twice. She is featured in our discussion on Oncofertility.
    By: Patient Power
    Promising Lymphoma News
    Andrew blogs from the first day of the 2010 Annual Meeting of the American Society of Hematology (ASH).
    By: Patient Power

    Our Partners in Lymphoma:

    Lymphoma Foundation of AmericaChicago Blood Cancer FoundationPatients Against Lymphoma